Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
14 February 2012Website:
http://www.organovo.comNext earnings report:
09 August 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | 73 min agoDividend
Analysts recommendations
Institutional Ownership
ONVO Latest News
Organovo is scheduled to share information about its primary clinical-stage medication, FXR314, at DDW2024, taking place in Washington, D.C. from May 18-21, 2024.
Organovo Holdings announced on Monday that its experimental drug for a certain type of fatty liver disease achieved the primary objective in a mid-stage trial, causing its stock to rise by almost 27% in premarket trading.
SAN DIEGO, Sept. 08, 2023 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO) (Organovo), a clinical stage biotechnology company that is focused on developing novel human therapies with high fidelity in three-dimensional (3D) human tissues that recapitulate key aspects of human disease, today announced that Keith Murphy, Founder and Executive Chairman, will present a corporate update and hold meetings with institutional investors during the H.C. Wainwright 25th Annual Global Investment Conference being held September 11-13, 2023.
What type of business is Organovo Holdings?
Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company offers ExVive human liver tissue and ExVive human kidney tissue used for predictive preclinical testing of drug compounds. The company was incorporated in 2007 and is headquartered in Solana Beach, California.
What sector is Organovo Holdings in?
Organovo Holdings is in the Healthcare sector
What industry is Organovo Holdings in?
Organovo Holdings is in the Biotechnology industry
What country is Organovo Holdings from?
Organovo Holdings is headquartered in United States
When did Organovo Holdings go public?
Organovo Holdings initial public offering (IPO) was on 14 February 2012
What is Organovo Holdings website?
https://www.organovo.com
Is Organovo Holdings in the S&P 500?
No, Organovo Holdings is not included in the S&P 500 index
Is Organovo Holdings in the NASDAQ 100?
No, Organovo Holdings is not included in the NASDAQ 100 index
Is Organovo Holdings in the Dow Jones?
No, Organovo Holdings is not included in the Dow Jones index
When does Organovo Holdings report earnings?
The next expected earnings date for Organovo Holdings is 09 August 2024